Pierwsze badania przeprowadzono w latach dziewidziesitych na Uniwersytecie w Zagrzebiu przez grup badawcz profesora Predraga Sikicia
Chronic Illness and Inflammation: Conditions such as diabetes, autoimmune disorders, heart disease, and chronic infections significantly reduce glutathione levels
Subsequent mass spectrometry analysis identified interacting proteins, with AFG3-like matrix AAA peptidase subunit 2 (AFG3L2), a mitochondrial inner membrane m-AAA protease, highlighted as a key interactor
One more honest note for the Canadian reader
GLP-1 Microdosing: A Smarter, Slower Approach GLP-1 microdosing is a more personalized, intentional way to help support your metabolism and health
First improvement at 1 to 2 weeks, significant change by week 4